JCR Pharmaceuticals Co., Ltd. (4552.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 69.26B |
| Enterprise Value | 109.15B |
| P/E Ratio | -17.71 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 1.55 |
| Price/Book Ratio | 1.47 |
| Enterprise/Revenue | 2.91 |
| Enterprise/EBITDA | -282.73 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | -0.09 |
| Operating Margin | -0.14 |
AD
Management Effectiveness
| Return On Assets | -0.03 |
| Return On Equity | -0.08 |
Income Statement
| Revenue | 40.32B |
| Revenue/Share | 318.54 |
| Gross Profit | 30.06B |
| EBITDA | 6.18B |
| Net Income | 2.18B |
| Diluted EPS | 17.85 |
Balance Sheet
| Total Cash | 10.44B |
| Total Cash/Share | 85.38 |
| Total Debt | 63.66B |
| Total Debt/Equity | 1.55 |
| Current Ratio | 0.93 |
| Book Value Per Share | 338.67 |
Price History
| 52-Week Change | -18.51 |
| 52-Week High | 824 |
| 52-Week Low | 444 |
| Moving Average 50 Days | 515.56 |
| Moving Average 200 Days | 540.04 |
Statistics
| Average Volume | 822,648 |
| Shares Outstanding | 122.02M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 20 |
| Trailing Annual Dividend Yield | 4.06 |
| Payout Ratio | -0.18 |
| Last Split Factor | 4:1 |
| Last Split Date | September 29, 2020 |
AD
